| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e980495c52ad12fe0ec5e81debda187 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-208
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-404 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F13-00063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L75-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F13-0253
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-58 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F13-00 |
| filingDate |
2017-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78b2c7d9e5f6243d0daed3e7e5560049 |
| publicationDate |
2020-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10758426-B2 |
| titleOfInvention |
Antimicrobial hydrogel formulation |
| abstract |
A hydrogel formulation is provided for use with a film. The hydrogel formulation includes a medical-grade hydrogel and an antimicrobial substance. This hydrogel formulation may be coated onto one or more surfaces of a medical-grade transparent film suitable for a wound dressing. The antimicrobial material may be a silane quaternary ammonium salt. The silane quaternary ammonium salt may comprise 3-(trimethoxysilyl) propyldimethyloctadecyl ammonium chloride. The 3-(trimethoxysilyl) propyldimethyloctadecyl ammonium chloride may constitute about 72% by weight of the silane quaternary ammonium salt. The medical-grade hydrogel may comprise a colloidal gel in which the particles are dispersed in water. Further, the hydrogel formulation may include about 0.01% to about 60% by weight of the antimicrobial substance. The transparent film may further include a release liner applied over the coated side(s) of the transparent film. The transparent film may comprise polyurethane. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11771819-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11458044-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11241339-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10993441-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11653995-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11723808-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11740241-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11116884-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11596554-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10980236-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11266774-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11583430-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10968543-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11628093-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11369114-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11452808-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11135315-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11241525-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11331221-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11286601-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11033031-B1 |
| priorityDate |
2012-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |